Delta9-tetrahydrocannabinol

Compton WM, Grant BF, Colliver JD, et al Prevalence of marijuana use disorders in the United States 1991-1992 and2001-2002. JAMA291 2114-2121,2004 Cook SA, Lowe JA, Martin BR CBl receptor antagonist precipitates withdrawal in mice exposed to delta9-tetrahydrocannabinol. J Pharmacol Exp Ther 285 1150— 1156, 1998... [Pg.177]

Wu, X. and French, E.D., Effects of chronic delta9-tetrahydrocannabinol on rat midbrain dopamine neurons an electrophysiological assessment, Neuropharmacology, 39, 391, 2000. [Pg.17]

Braida, D., Losue, S., Pegorini, S., and Sala, M., Delta9-tetrahydrocannabinol-induced conditioned place preference and intracerebroventricular self-administration in rats, Eur. J. Pharmacol., 506, 63, 2004. [Pg.17]

Sierra V, Duttaroy A, Lutfy K, Candido J, Billings B, Zito SW, Yoburn BC. (1992). Potentiation of opioid analgesia by cocaine the role of spinal and supraspinal receptors. Life Sci. 50(8) 591-97. Smith FL, Cichewicz D, Martin ZL, Welch SP. (1998). The enhancement of morphine anti nociception in mice by delta9-tetrahydrocannabinol. Pharmacol Biochem Behav. 60(2) 559-66. [Pg.531]

Smith FL, Fujimori K, Lowe J, Welch SP. (1998). Characterization of delta9-tetrahydrocannabinol and anandamide antinociception in nonarthritic and arthritic rats. Pharmacol Biochem Behav. 60(1) 183-91. [Pg.531]

Belgrave BE, Bird KD, Chesher GB, Jackson DM, Lubbe KE, Starmer GA, Teo RK. (1979). The effect of (—) trans-delta9-tetrahydrocannabinol, alone and in combination with ethanol, on human performance. Psychopharmacology (Berlin). 62(1) 53-60. [Pg.555]

Carta G, Nava F, Gessa GL. (1998). Inhibition of hippocampal acetylcholine release after acute and repeated Delta9-tetrahydrocannabinol in rats. Brain Res. 809(1) 1-4. [Pg.556]

Chan GC, Hinds TR, Impey S, Storm DR. (1998). Hippocampal neurotoxicity of Delta9-tetrahydrocannabinol. J Neurosci. 18(14) 5322-32. [Pg.556]

Drewnowski A, Grinker JA. (1978). Food and water intake, meal patterns, and activity of obese and lean Zucker rats following chronic and acute treatment with delta9-tetrahydrocannabinol. Pharmacol Biochem Behav. 9(5) 619-30. [Pg.558]

Garrett ER, Hunt CA. (1977). Pharmacokinetics of delta9-tetrahydrocannabinol in dogs. J Pharm Sci. 66(3) 395-407. [Pg.559]

Hampson AJ, Grimaldi M, Axelrod J, Wink D. (1998). Cannabidiol and (-)Delta9-tetrahydrocannabinol are neuroprotective antioxidants. Proc Natl Acad Sci USA. 95(14) 8268-73. [Pg.560]

Mallet PE, Beninger RJ. (1998). The cannabinoid CBl receptor antagonist SR141716A attenuates the memory impairment produced by delta9-tetrahydrocannabinol or anandamide. Psychopharmacology (Berlin). 140(1) 11-19. [Pg.562]

Peters BA, Lewis EG, Dustman RE, Straight RC, Beck EC. (1976). Sensory, perceptual, motor, and cognitive functioning and subjective reports following oral administration of delta9-tetrahydrocannabinol. Psychopharmacologia. 47(2) 141-48. [Pg.564]

Shen M, Thayer SA. (1999). Delta9-tetrahydrocannabinol acts as a partial agonist to modulate glutamatergic synaptic transmission between rat hippocampal neurons in culture. Mol Pharmacol. 55(1) 8-13. [Pg.565]

Sofia RD, Solomon TA, Barry H 3rd. (1976). Anticonvulsant activity of delta9-tetrahydrocannabinol compared with three other drugs. EurJ Pharmacol. 35(1) 7-16. [Pg.565]

Breindahl T, Andreasen K. 1999. Determination of 11-nor-delta9-tetrahydrocannabinol-9-carboxylic acid in urine using high-performance liquid chromatography and electrospray ionization mass spectrometry. J Chromatogr B Biomed Sci Appl 732 155. [Pg.169]

Maralikova B, Weinmann W. 2004 Simultaneous determination of Delta9-tetrahydrocannabinol, ll-hydroxy-Delta9-tetrahydrocannabinol and ll-nor-9-carboxy-Delta9-tetra-hydrocannnabinol in human plasma by high-performance liquid chromatography/tandem mass spectrometry. J Mass Spectrom 39 526. [Pg.173]

Tai SS, Welch MJ. 2000. Determination of ll-nor-delta9-tetrahydrocannabinol-9-carboxylic acid in a urine-based standard reference material by isotope-dilution liquid chromatography-mass spectrometry with electrospray ionization. J Anal Toxicol 24 385. [Pg.175]

Kanter, S. L., M. R. Musumeci and L. E. Hollister. Quantitative determination of delta9-tetrahydrocannabinol and delta9-tetrahydrocannabinolic acid in marihuana by high-pressure liquid chromatography. J Chromatogr 1979 171 504. [Pg.100]

Baker, et al. Medicinal cannabis is delta9-tetrahydrocannabinol necessary for all its effects J Pharm Pharmacol CS324 2003 55(12) 1687-1694. [Pg.108]

Gustafson, R.A. et al., Urinary cannabinoid detection times after controlled oral administration of delta9-tetrahydrocannabinol to humans, Clin. Chem., 49(7), 1114-1124, 2003. [Pg.49]

Wiley JL, Martin BR (1999) Effects of SR141716A on diazepam substitution for delta9-tetrahydrocannabinol in rat drug discrimination. Pharmacol Biochem Behav 64 519... [Pg.478]

Garcia-Gil, F., Ramos, J. A., Rubino, T., Parolaro, D., and Fernandez-Ruiz, J. J. (1998). Perinatal delta9-tetrahydrocannabinol exposure did not alter dopamine transporter and tyrosine hydroxylase mRNA levels in midbrain dopaminergic neurons of adult male and female rats. Neurotoxicol. Teratol. 20, 549—553. [Pg.130]

Robandt PV, Klette KL, Sibum M (2009) Automated solid-phase extraction-liquid chromatography-tandem mass spectrometry analysis of 1 l-nor-Delta9-tetrahydrocannabinol-9-car-boxylic acid in human urine specimens application to a high-throughput urine analysis laboratory. J Anal Toxicol 33(8) 456 f60... [Pg.396]

Hejazi N, Zhou C, Oz M, Sun H, Ye JH, Zhang L (2006) Delta9-tetrahydrocannabinol and endogenous cannabinoid anandamide directly potentiate the function of glycine receptors. Mol... [Pg.500]

Breivogel CS, ChUders SR, Deadwyler SA, Hampson RE, Vogt LJ, Sim-SeUey LJ (1999) Chronic delta9-tetrahydrocannabinol treatment produces a time-dependent loss of cannabinoid receptors and cannabinoid receptor-activated G proteins in rat brain. J Neurochem 73 2447-2459... [Pg.70]

Romero J, Garcia-Palomero E, Castro JG, Garcia-Gil L, Ramos JA, Fernandez-Ruiz JJ (1997) Effects of chronic exposure to delta9-tetrahydrocannabinol on cannabinoid receptor binding and mRNA levels in several rat brain regions. Brain Res Mol Brain Res 46 100-108... [Pg.76]

Shivachar AC, Martin BR, Ellis EF (1996) Anandamide- and delta9-tetrahydrocannabinol-evoked arachidonic acid mobUization and blockade by SR141716A [N-(Piperidin-l-yl)-5-(4-chlorophenyl)-l-(2,4-dichlorophenyl)-4-methyl-lH-pyrazole-3-carboximide hydrochloride]. Biochem Pharmacol 51 669-676... [Pg.77]

Sim LJ, Hampson RE, Deadwyler SA, ChUders SR (1996) Effects of chronic treatment with delta9-tetrahydrocannabinol on cannabinoid-stimulated [35S]GTPgammaS autoradiography in rat brain. J Neurosci 16 8057-8066... [Pg.77]

Romero J, Berrendero F, Manzanares J, Perez A, Corchero J, Fuentes J, Fernandez-Ruiz J, Ramos J (1998b) Time-course of the cannabinoid receptor down-regulation in the adult rat brain caused by repeated exposure to delta9-tetrahydrocannabinoL Synapse 30 298-308... [Pg.113]

Bhargava HN (1976b) Inhibition of naloxone-induced withdrawal in morphine dependent mice by l-trans-delta9-tetrahydrocannabinoL Eur J Pharmacol 36 259-262... [Pg.137]

Cook SA, Lowe JA, Martin BR (1998) CBi receptor antagonist precipitates withdrawal in mice exposed to Delta9-tetrahydrocannabinoL J Pharmacol Exp Ther 285 1150-1156... [Pg.138]

Kaymakcalan S, Ayhan IH, Tulunay FC (1977) Naloxone-induced or postwithdrawal abstinence signs in delta9-tetrahydrocannabinol-tolerant rats. Psychopharmacology (Berl) 55 243-249... [Pg.141]

Ko MC, Woods JH (1999) Local administration of delta9-tetrahydrocannabinol attenuates capsaicin-induced thermal nociception in rhesus monkeys a peripheral cannabinoid action. Psychopharmacology (Berl) 143 322-326... [Pg.141]

Roth SH (1978) Stereospecific presynaptic inhibitory effect of delta9-tetrahydrocannabinol on cholinergic transmission in the myenteric plexus of the guinea pig. Can J Physiol Pharmacol 56 968-975... [Pg.324]

Freedland CS, Whitlow CT, MUler MD, Porrino LJ (2002) Dose-dependent effects of delta9-tetrahydrocannabinol on rates of local cerebral glucose utilization in rat. Synapse 45 134-142... [Pg.441]

Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...